Abstract
The definition of pathologic myopia had not been standardized for a long time, and PM was often confused with high myopia. However, “high myopia” is defined as an eye with a high degree of myopic refractive error, and “pathologic myopia” is defined as myopic eyes with the presence of pathologic lesions in the posterior fundus. The lesions defying pathologic myopia are myopic maculopathy equal to or more serious than diffuse choroidal atrophy and/or the presence of a posterior staphyloma.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Myopia is a significant public health concern worldwide [1,2,3]. It is estimated that by 2050, there will be 4.8 billion people with myopia which is approximately one-half (49.8%) of the world population. Of these, 938 million individuals will have high myopia which is 9.8% of the world population [4].
Although most myopic patients obtain good vision with optic correction of refractive error, the exception is pathologic myopia (PM). Eyes with PM develop different types of fundus lesions, called myopic maculopathy, which can lead to a significant reduction of central vision [5, 6]. In fact, myopic maculopathy in eyes with PM is a major cause of blindness worldwide, especially in East Asian countries [10,11,12,13,11].
The definitions of myopia and pathologic myopia have not been standardized, and the term “pathologic myopia” is often confused with “high myopia.” However, these two are distinctly different. “High myopia” is defined as an eye with a high degree of myopic refractive error, and “pathologic myopia” is defined as myopic eyes with the presence of pathologic lesions in the posterior fundus. Duke-Elder defined “pathologic myopia,” as “that type of myopia which is accompanied by degenerative changes occurring especially in the posterior pole of the globe” [12].
Myopia is defined as a refractive condition of the eye in which parallel rays of light entering the eye are brought to a focus in front of the retina when the ocular accommodation is relaxed [13]. This refractive status is dependent on the axial length, and a disproportionate increase of the axial length of the eye can lead to myopia, called axial myopia, or a disproportionate increase in the refractive power of the eye can also lead to myopia, called refractive myopia. The WHO Report defines myopia as “a condition in which the refractive error (spherical equivalent) is ≤ –0.50 diopter (D) in either eye” [3].
Myopia is classified into low myopia, moderate myopia, and high myopia. The cutoff values for the different degrees have not been consistent among studies. The WHO Report defined “high myopia” as “a condition in which the objective refractive error (spherical equivalent) is ≤ –5.00 D in either eye” [3]. Very recently, Flitcroft on behalf of the International Myopia Institute (IMI) proposed a set of standards to define and classify myopia [13]. Low myopia is defined as a refractive error of ≤ −0.50 and > −6.00, and high myopia is defined as refractive error of ≤ −6.00 D [13]. The Japan Myopia Society proposed a category of “moderate myopia” between “low myopia” and “high myopia” (http://www.myopiasociety.jp/member/guideline/index.html). According to this society, low myopia was defined as a refractive error of ≤ −0.50 and > −3.00 D, moderate myopia is ≤ −3.00 and > −6.00 D, and high myopia is ≤ −6.00 D. Table 2.1 shows a modified summary of the classification of different degrees of myopia and PM.
As mentioned above, PM is classified as being present when myopic eyes have characteristic lesions in the posterior fundus. The changes are the presence of myopic maculopathy equal to or more serious than diffuse choroidal atrophy (equal to Category 2 in the META-PM classification [5]) and/or the presence of a posterior staphyloma [14]. The cutoff values of the myopic refractive error and axial length should not be set for the definition of pathologic myopia because a posterior staphyloma has been reported to occur in eyes with normal axial length (Fig. 2.1) [15] and even in eyes with axial lengths <26.5 mm [16]. This suggested that PM occurs independently of the axial length of the eye.
References
Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739–48.
Resnikoff S, Jonas JB, Friedman D, et al. Myopia – a 21st century public health issue. Invest Ophthalmol Vis Sci. 2019;60(3):Mi–Mii.
Institute WHO-BHV. The impact of myopia. The impact of myopia and high myopia report of the joint World Health Organization – Brien Holden Vision Institute Globa Scientific Meeting on Myopia. Available at: https://www.visionuk.org.uk/download/WHO_Report_Myopia_2016.pdf.2016.
Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–42.
Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol. 2015;159(5):877–83.
Fang Y, Yokoi T, Nagaoka N, et al. Progression of myopic maculopathy during 18-year follow-up. Ophthalmology. 2018;125(6):863–77.
Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology. 2006;113(8):1354–62.
Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology. 2006;113(7):1134 e1–11.
Buch H, Vinding T, La Cour M, et al. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology. 2004;111(1):53–61.
Cotter SA, Varma R, Ying-Lai M, et al. Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113(9):1574–82.
Varma R, Kim JS, Burkemper BS, et al. Prevalence and causes of visual impairment and blindness in Chinese American adults: the Chinese American Eye Study. JAMA Ophthalmol. 2016;134(7):785–93.
Duke-Elder S, editor. Pathological refractive errors. St. Louis: Mosby; 1970.
Flitcroft DI, He M, Jonas JB, et al. IMI – defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20–30.
Ohno-Matsui K, Lai TYY, Cheung CMG, Lai CC. Updates of pathologic myopia. Prog Retin Eye Res. 2016;52(5):156–87.
Moriyama M, Ohno-Matsui K, Hayashi K, et al. Topographical analyses of shape of eyes with pathologic myopia by high-resolution three dimensional magnetic resonance imaging. Ophthalmology. 2011;118(8):1626–37.
Wang NK, Wu YM, Wang JP, et al. Clinical characteristics of posterior staphylomas in myopic eyes with axial length shorter than 26.5 mm. Am J Ophthalmol. 2016;162:180–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ohno-Matsui, K. (2021). Definition of Pathologic Myopia (PM). In: Spaide, R.F., Ohno-Matsui, K., Yannuzzi, L.A. (eds) Pathologic Myopia. Springer, Cham. https://doi.org/10.1007/978-3-030-74334-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-74334-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74333-8
Online ISBN: 978-3-030-74334-5
eBook Packages: MedicineMedicine (R0)